Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10–12 October 2018, Bethesda, MD, USA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10–12 October 2018, Bethesda, MD, USA

Published:2019-01 Issue:1 Volume:5 Page:50-59
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Kuo Lillian,Lawrence Diane,McDonald David,Refsland Eric,Bridges Sandra,Smiley Stephen,Tressler Randall L.,Beaubien Candice,Salzwedel Karl

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference42 articles.

1. A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection;Sneller;Sci Transl Med,2017

2. Early antibody therapy can induce long-lasting immunity to SHIV;Nishimura;Nature,2017

3. Sustained virologic control in SIV+ macaques after antiretroviral and alpha4beta7 antibody therapy;Byrareddy;Science,2016

4. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane;Wang;Proc Natl Acad Sci U S A,2018

5. Single-cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency;Bradley;Cell Rep,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections;Nature Communications;2023-06-22

2. A trispecific Ab directed to HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections;2022-08-12

3. The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T CM Cell Model of Latency;Journal of Virology;2021-03-10

4. TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption;PLOS Pathogens;2021-02-18

5. “I would really want to know that they had my back”: Transgender women’s perceptions of HIV cure-related research in the United States;PLOS ONE;2020-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3